QSAR and drug design : new developments and applications /
Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Amsterdam ; New York :
Elsevier,
1995.
|
Colección: | Pharmacochemistry library ;
v. 23. |
Temas: | |
Acceso en línea: | Texto completo Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn162589413 | ||
003 | OCoLC | ||
005 | 20231117015004.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 070806s1995 ne a ob 101 0 eng d | ||
040 | |a OPELS |b eng |e pn |c OPELS |d OCLCG |d OPELS |d OCLCQ |d N$T |d YDXCP |d IDEBK |d UBY |d E7B |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCQ |d OCLCF |d OCLCO |d OCL |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d UAB |d PHUST |d OCLCQ |d CASUM |d KIJ |d STF |d D6H |d OCLCQ |d OCLCO |d OCLCA |d LEAUB |d OL$ |d VLY |d S2H |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d OCLCO |d COM |d OCLCO |d OCLCQ |d OCL |d OCLCQ |d OCLCO | ||
019 | |a 180771381 |a 505140924 |a 648350913 |a 989454925 |a 1011165601 |a 1011166521 |a 1027489118 |a 1035654675 |a 1119411902 |a 1162426061 | ||
020 | |a 9780444886156 | ||
020 | |a 044488615X | ||
020 | |a 9780080545004 |q (electronic bk.) | ||
020 | |a 0080545009 |q (electronic bk.) | ||
020 | |a 1281058580 | ||
020 | |a 9781281058584 | ||
020 | |a 9786611058586 | ||
020 | |a 6611058583 | ||
035 | |a (OCoLC)162589413 |z (OCoLC)180771381 |z (OCoLC)505140924 |z (OCoLC)648350913 |z (OCoLC)989454925 |z (OCoLC)1011165601 |z (OCoLC)1011166521 |z (OCoLC)1027489118 |z (OCoLC)1035654675 |z (OCoLC)1119411902 |z (OCoLC)1162426061 | ||
050 | 4 | |a RM301.42 |b .Q28 1995eb | |
060 | 4 | |a W1 |b PH272L v.23 1995 | |
060 | 4 | |a QV 744 |b Q102 1995 | |
070 | |a RS402.P42 |b v.23 | ||
072 | 0 | |a X380 | |
072 | 7 | |a MED |x 023000 |2 bisacsh | |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
072 | 7 | |a MED |x 072000 |2 bisacsh | |
072 | 7 | |a MED |x 058170 |2 bisacsh | |
082 | 0 | 4 | |a 615/.19 |2 22 |
245 | 0 | 0 | |a QSAR and drug design : |b new developments and applications / |c edited by Toshio Fujita. |
260 | |a Amsterdam ; |a New York : |b Elsevier, |c 1995. | ||
300 | |a 1 online resource (xiv, 493 pages) : |b illustrations (some color) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Pharmacochemistry library ; |v v. 23 | |
520 | |a Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three sections. Section one includes topics illustrating newer methodologies relating to ligand-receptor, molecular graphics and receptor modelling as well as the three-dimensional (Q)SAR examples with the active analogue approach and the comparative molecular field analysis. In section 2 the hydrophobicity parameters, log P (1-octanol/water) for compound series of medicinal-chemical interest are analysed physico-organic chemically. Section 3 contains the examples based on the traditional Hansch QSAR approach. A variety of methodologies and procedures are presented in this single volume, along with their methodological philosophies. | ||
500 | |a "Based on topics presented at the annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the biennial China-Japan Drug Design and Development Conference." | ||
504 | |a Includes bibliographical references and index. | ||
588 | 0 | |a Print version record. | |
505 | 0 | |a Front Cover; QSAR and Drug Design: New Developments and Applications; Copyright Page; Preface; Contents; Section I: Three-Dimensional Structure-Based Drug Design, Molecular Modelling and Three-Dimensional QSAR; Section II: Quantitative Structure-Parameter Analyses and Database-Oriented and Newer Statistical (Q)SAR Procedures and Drug Design; Sevtion III: Traditional QSAR and Drug Design.; Subject index. | |
546 | |a English. | ||
650 | 0 | |a Drugs |x Structure-activity relationships |v Congresses. | |
650 | 0 | |a QSAR (Biochemistry) |v Congresses. | |
650 | 0 | |a Drugs |x Design |v Congresses. | |
650 | 0 | |a Structure-activity relationships (Biochemistry) | |
650 | 0 | |a Drugs |x Design. | |
650 | 1 | 2 | |a Structure-Activity Relationship |0 (DNLM)D013329 |
650 | 2 | 2 | |a Drug Design |0 (DNLM)D015195 |
650 | 6 | |a M�edicaments |0 (CaQQLa)201-0028672 |x Relations structure-activit�e |0 (CaQQLa)201-0028672 |v Congr�es. |0 (CaQQLa)201-0378219 | |
650 | 6 | |a Relations structure-activit�e quantitatives (Biochimie) |0 (CaQQLa)201-0379113 |v Congr�es. |0 (CaQQLa)201-0378219 | |
650 | 6 | |a M�edicaments |0 (CaQQLa)201-0203461 |x Conception |0 (CaQQLa)201-0203461 |v Congr�es. |0 (CaQQLa)201-0378219 | |
650 | 6 | |a Relations structure-activit�e (Biochimie) |0 (CaQQLa)201-0028673 | |
650 | 6 | |a M�edicaments |x Conception. |0 (CaQQLa)201-0203461 | |
650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
650 | 7 | |a Structure-activity relationships (Biochemistry) |2 fast |0 (OCoLC)fst01135737 | |
650 | 7 | |a Drugs |x Design |2 fast |0 (OCoLC)fst00898790 | |
650 | 7 | |a Drugs |x Structure-activity relationships |2 fast |0 (OCoLC)fst00898929 | |
650 | 7 | |a QSAR (Biochemistry) |2 fast |0 (OCoLC)fst01084801 | |
655 | 2 | |a Congress |0 (DNLM)D016423 | |
655 | 7 | |a proceedings (reports) |2 aat |0 (CStmoGRI)aatgf300027316 | |
655 | 7 | |a Conference papers and proceedings |2 fast |0 (OCoLC)fst01423772 | |
655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
655 | 7 | |a Actes de congr�es. |2 rvmgf |0 (CaQQLa)RVMGF-000001049 | |
700 | 1 | |a Fujita, Toshio, |d 1929-2017. | |
776 | 0 | 8 | |i Print version: |t QSAR and drug design. |d Amsterdam ; New York : Elsevier, 1995 |z 044488615X |z 9780444886156 |w (DLC) 95045138 |w (OCoLC)33357280 |
830 | 0 | |a Pharmacochemistry library ; |v v. 23. | |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780444886156 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/publication?issn=01657208&volume=23 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/01657208/23 |z Texto completo |